Asa Schott

Asa Schott

Company: Idogen AB

Job title: Chief Scientific Officer


A Novel Tolerogenic Dendritic Cell Platform with the Potential to Present the Antigen FVIII to Induce Tolerance Against FVIII in Haemophilia A Patients 11:30 am

Presentation of a novel and patented platform for generation of tolerogenic DCs Hear how the tolerogenic DCs have a potential to induce regulatory T and to reduce antigen-specific T cell responses Learn how tolerogenic DCs loaded with FVIII can be used to treat haemophilia A patients who developed inhibitorsRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.